Rational design and synthesis of unsaturated 2,5-dioxopiperazine derivatives as potential protein tyrosine kinase inhibitors

Tetrahedron Letters

Volumn 39, Issue 40, 1998, Pages 7373-7376

  Li, Wen Ren ^a   Peng, Shao Zheng ^a  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CYCLIZATION; DRUG DESIGN; DRUG SYNTHESIS; IMMUNOMODULATION; SIGNAL TRANSDUCTION; TAIWAN;

EID: 0032190784     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01599-8     Document Type: Article

References (18)

1. 1. Levitzki, A. FASEB J. 1992, 6, 3275.
2. 2. Traxler, P.; Lydon, N. Drugs of the Future 1995, 20, 1274, and references therein.
3. 3. Wong, T. W.; Goldberg, A. R. J. Biol. Chem. 1984, 259, 3127.
4. 4. Umezawa, K.; Hori, T.; Tajima, H.; Imoto, M.; Isshiki, K.; Takeuchi, T. FEBS Lett. 1990, 260, 198.
5. 5. Green, J. J. Org. Chem. 1995, 60, 4287.
6. 6. Energy minimizations were accomplished according to MacroModel v3.1X Program using MM2 force field. The superimposition RMS (overlap deviation) is 0.021 Å, which showed an obviously good fit.
7. 7. Ramanjulu, J. M.; Ding, X.; Joullié, M. M.; Li, W.-R. J. Org. Chem. 1997, 62, 4961.
8. 8. Lam, K. S.; Lebl, M.; Krchnák, V. Chem. Rev. 1997, 97, 411, and references therein.
9. 9. Kowalski, J.; Lipton, M. A. Tetrahedron Lett. 1996, 37, 5839.
10. 10. Balkenhohl, F.; von dem Bussche-Hünnefeld, C.; Lansky, A.; Zechel, C. Angew. Chem. Int. Ed. Engl. 1996, 35, 2288, and references therein.
11. 11. Cheung, S. T.; Benoiton, N. L. Can. J. Chem. 1977, 55, 906.
12. 12. van der Auwera, C.; van Damme, S.; Anteunis, M. J. O. Int. J. Peptide Protein Res. 1987, 29, 464.
13. 13. Carpino, L. A.; Elfaham, A.; Albericio, F. Tetrahedron Lett. 1994, 35, 2279.
14. 14. Sarshar, S.; Siev, D.; Mjalli, A. M. Tetrahedron Lett. 1996, 37, 835.
15. 15. Chiral HPLC analysis of the 2,5-dioxopiperazines from solution and solid phase method indicated only slight racemization. HPLC analytical separation achieved using a CHIRALCEL OJ column, eluting with ethanol at 1 ml/min.
16. 16. Boojamra, C. G.; Burow, K. M.; Ellman, J. A. J. Org. Chem. 1995, 60, 5742.
17. 17. Kaljuste, K.; Undén, A. Int. J. Peptide Protein Res. 1993, 42, 118.
18. 18. Coy, D. H.; Sasaki, Y. Peptides 1987, 8, 119.